BRIEF-Xoma established proof-of-concept for its product candidate 358 in congenital hyperinsulinism and hypoglycemia post-bariatric surgery
* Xoma Corp- Established proof-of-concept for its product candidate 358 in congenital hyperinsulinism and hypoglycemia post-bariatric surgery Source text for Eikon: Further company coverage: [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: hyperinsulinism, congenital, proof-of-concept, coverage, company, Further, Eikon, surgery Source, hypoglycemia post-bariatric, product candidate, Established, Corp-, surgery, post-bariatric, hypoglycemia, candidate, product, established, BRIEF-Xoma
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/cHZyfTfjyTI/idUSFWN1FL0VK